Restoring Connexin-36 Function in Diabetogenic Environments Precludes Mouse and Human Islet Dysfunction

Abstract

ABSTRACTType2 diabetes results from failure of the β-cell to compensate for insulin resistance, such as in obesity. Insulin secretion is governed by a series of metabolic and electrical events which can fail during the progression of diabetes. β-cells are electrically coupled via Cx36 gap junction channels, thereby coordinating the pulsatile dynamics of electrical activity, Ca2+ and insulin release across the islet, enhancing insulin action. Pulsatile insulin release is disrupted in human type2 diabetes, although whether this disruption results from diminished gap junction coupling is unclear. Factors such as pro-inflammatory cytokines and free fatty acids disrupt gap junction coupling under invitro conditions. Here we test whether gap junction coupling and coordinated Ca2+ dynamics are disrupted in type2 diabetes, and whether recovery of gap junction coupling can recover islet function. We examine islets from healthy donors and those with type2 diabetes, as well as islets from db/db mice and islets treated with a cocktail of proinflammatory cytokines (TNF-α, IL-1β, IFN-γ) or free fatty acids (palmitate). We modulate gap junction coupling using Cx36 over-expression or pharmacological activation via modafinil. We also develop a peptide mimetic (S293) of the c-terminal regulatory tail of Cx36 designed to compete against its phosphorylation and downregulation. Cx36 gap junction permeability and coordinated Ca2+ dynamics were disrupted in islets from human donors with type2 diabetes, as well as in islets from db/db mice or treated with proinflammatory cytokines or palmitate. Cx36 over-expression, modafinil treatment and S293 peptide all enhanced Cx36 gap junction coupling and protected against declines in coordinated Ca2+ dynamics. Cx36 over-expression and S293 peptide also reduced apoptosis induced by proinflammatory cytokines. Critically S293 peptide rescued gap junction coupling and Ca2+ dynamics in islets from both db/db mice and a sub-set of T2D donors. Thus, recovering or enhancing Cx36 gap junction coupling can improve islet function in diabetes.